Vote Scores

Home / Companies / Prelude Therapeutics Incorporated / 12 Jun 2025

Meeting · year to 30 June 202542 filers reporting

Prelude Therapeutics Incorporated: meeting of 12 Jun 2025

Votes reported on Form N-PX, item by item

42 Form N-PX filers reported votes at the Prelude Therapeutics Incorporated meeting of 12 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 59.9% of reported votes for; 32 filers withheld from or voted against at least one nominee.

137 vote records from 42 filers. 3 of the 42 filers that marked the item either way voted against management.

26.2% for0.0% against73.8% other7.1% against management42 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

69 vote records from 42 filers. 0 of the 42 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management42 filers100.0% for0.0% against0.0% against management2,648,596 reported shares
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

68 vote records from 41 filers. 5 of the 41 filers that marked the item either way voted against management.

87.8% for12.2% against12.2% against management41 filers99.4% for0.6% against0.6% against management2,647,596 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Auditor
VanguardForFor
BlackRock and iSharesSplit or no voteFor
FidelityForFor
State Street and SPDRSplit or no voteFor
EquitableForFor
Charles SchwabSplit or no voteFor
Nuveen and TIAASplit or no voteFor
ProShares and ProFundsSplit or no voteFor
John Hancock and ManulifeForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *For
Northern Trust and FlexSharesSplit or no voteFor
T. Rowe PriceForFor
Lincoln FinancialSplit or no voteFor
NationwideSplit or no voteFor
Guggenheim and RydexSplit or no voteFor
Pacific Life fundsSplit or no voteFor
Global XAbstain or withhold *For
DWSAbstain or withhold *For

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Prelude Therapeutics Incorporated meeting?

42 Form N-PX filers reported votes at the meeting of 12 Jun 2025. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Prelude Therapeutics Incorporated on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Prelude Therapeutics Incorporated

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Prelude Therapeutics Incorporated with a meeting date within three days of 12 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.